{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:36:37Z","timestamp":1790861797522,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.clinthera.2005.11.003","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T23:48:05Z","timestamp":1135295285000},"page":"1806-1814","source":"Crossref","is-referenced-by-count":16,"title":["Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: A retrospective analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Menno E.","family":"van der Elst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel L.","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J.","family":"de Blaey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthonius","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2005.11.003_bib1","series-title":"Demographic Yearbook 1997","year":"1998"},{"key":"10.1016\/j.clinthera.2005.11.003_bib2","unstructured":"Available at: www.cbs.nl StatlinePopulation, monthly and yearly data [Statistics Netherlands Web site]Accessed May 17, 2005"},{"key":"10.1016\/j.clinthera.2005.11.003_bib3","unstructured":"Available at: www.americanheart.org\/downloadable\/heart\/l0148328094661013190990123HS_State_02.pdf,2002 Heart and Stroke Statistical Update [American Heart Association Web site] Accessed May 17, 2005"},{"key":"10.1016\/j.clinthera.2005.11.003_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2005.11.003_bib5","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: Systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2005.11.003_bib6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/bmj.316.7134.838","article-title":"Secondary prevention in acute myocardial infarction","volume":"316","author":"Mehta","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2005.11.003_bib7","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1345\/aph.1C450","article-title":"Drug therapy for prevention of recurrent myocardial infarction","volume":"37","author":"van der Elst","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2005.11.003_bib8","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.282.21.2058","article-title":"Oral anticoagulant therapy in patients with coronary artery disease: A meta-analysis","volume":"282","author":"Anand","year":"1999","journal-title":"JAMA"},{"issue":"Suppl A","key":"10.1016\/j.clinthera.2005.11.003_bib9","first-page":"Al2","article-title":"European and American recommendations for disease prevention","volume":"19","author":"Wood","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2005.11.003_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s002280050446","article-title":"Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period","volume":"54","author":"Martinez","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2005.11.003_bib11","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/S0735-1097(00)00996-7","article-title":"Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: The National Registry ofMyocardial Infarction 1, 2 and 3","volume":"36","author":"Rogers","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2005.11.003_bib12","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.163.12.1430","article-title":"National and state trends in quality of care for acute myocardial infarction between 1994\u20131995 and 1998\u20131999: The Medicare health care quality improvement program","volume":"163","author":"Burwen","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2005.11.003_bib13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(00)04235-5","article-title":"Clinical reality of coronary prevention guidelines: A com parison of EUROASPIRE I and II in nine countries","volume":"357","author":"European Action on Secondary Prevention by Intervention to Reduce Events","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2005.11.003_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/fampra\/15.5.457","article-title":"Is prophylactic treatment after myocardial infarction evidence-based","volume":"15","author":"Brotons","year":"1998","journal-title":"Fam Pract"},{"key":"10.1016\/j.clinthera.2005.11.003_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/mhj.2003.143","article-title":"Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence","volume":"145","author":"Simpson","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2005.11.003_bib16","unstructured":"Available at: www.pharmo.nl\/pdf\/reports\/Chronic%20Pharmacotherapy%20Forever.pdfHeringsR.M.C.LeufkensH.G.M.HeerdinkE.R.Chronic Pharmacotherapy Forever [Pharmo Institute Web site]Accessed May 17, 2005"},{"key":"10.1016\/j.clinthera.2005.11.003_bib17","unstructured":"Available at:www.pharmo.nlPharmo Record Linkage System database [Pharmo Institute Web site]Accessed May 17, 2005"},{"key":"10.1016\/j.clinthera.2005.11.003_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jech.46.2.136","article-title":"Pharmaco-morbidity linkage: A feasibility study comparing morbidity in two pharmacy based exposure cohorts","volume":"46","author":"Herings","year":"1992","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.clinthera.2005.11.003_bib19","series-title":"Pharmacoepidemiology","first-page":"347","article-title":"Automated pharmacy record linkage in the Netherlands","author":"Leuflkens","year":"2000"},{"key":"10.1016\/j.clinthera.2005.11.003_bib20","series-title":"International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)","author":"US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics (NCHS)","year":"2003"},{"key":"10.1016\/j.clinthera.2005.11.003_bib21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0895-4356(01)00396-1","article-title":"Comparison of different methods to estimate prevalence of drug use by using pharmacy records","volume":"54","author":"Mantel-Teeuwisse","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2005.11.003_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0895-4356(99)00194-8","article-title":"Use of prevalence and incidence measures to describe age related prescribing of antidepressants with and without anticholinergic effects","volume":"53","author":"van Eijk","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2005.11.003_bib23","first-page":"V53","article-title":"Aspirin and secondary mortality after myocardial infarction","volume":"62","author":"Elwood","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2005.11.003_bib24","first-page":"V59","article-title":"Aspirin in coronary heart disease","volume":"62","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2005.11.003_bib25","first-page":"V63","article-title":"The German-Austrian aspirin trial: A comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction","volume":"62","author":"Breddin","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2005.11.003_bib26","first-page":"V79","article-title":"The aspirin myocardial infarction study: Final results","volume":"62","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2005.11.003_bib27","first-page":"V85","article-title":"The Persantineaspirin reinfarction study","volume":"62","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2005.11.003_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.296.6618.320","article-title":"Secondary prevention of vascular disease by prolonged antiplatelet treatment","volume":"296","year":"1988","journal-title":"BMJ (Clip Res Ed)"},{"key":"10.1016\/j.clinthera.2005.11.003_bib29","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2005.11.003_bib30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2005.11.003_bib31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: An overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.clinthera.2005.11.003_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1021790112182","article-title":"Antihypertensive medication and quality of life-silent treatment of a silent killer?","volume":"16","author":"Bremner","year":"2002","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.clinthera.2005.11.003_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1388-9842(02)00256-8","article-title":"Patterns of pharmacotherapy in patients hospitalised for congestive heart failure","volume":"5","author":"Bouvy","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinthera.2005.11.003_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2005.11.003_bib35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0895-4356(97)00040-1","article-title":"Validation of pharmacy records in drug exposure assessment","volume":"50","author":"Lau","year":"1997","journal-title":"J Clin Epidemiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805002821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805002821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T11:24:16Z","timestamp":1547897056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291805002821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0149291805002821"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2005.11.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}